0002129660-26-000001.txt : 20260415 0002129660-26-000001.hdr.sgml : 20260415 20260415110554 ACCESSION NUMBER: 0002129660-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260415 DATE AS OF CHANGE: 20260415 EFFECTIVENESS DATE: 20260415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SONIRE Therapeutics Inc. CENTRAL INDEX KEY: 0002129660 ORGANIZATION NAME: EIN: 301458329 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-580510 FILM NUMBER: 26863055 BUSINESS ADDRESS: STREET 1: 214 HOMER AVE CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: (650)460-9879 MAIL ADDRESS: STREET 1: 214 HOMER AVE CITY: PALO ALTO STATE: CA ZIP: 94301 D 1 primary_doc.xml X0708 D LIVE 0002129660 SONIRE Therapeutics Inc. 214 HOMER AVE PALO ALTO CA CALIFORNIA 94301 (650)460-9879 DELAWARE None None Corporation true 2025 Tohru Satoh 214 Homer Ave Palo Alto CA CALIFORNIA 94301 Executive Officer Director Promoter Koji Yasuda 4-1-4 Hongo, Bunkyo-ku Tokyo M0 JAPAN 113-0033 Director Jun Okamoto 803 Nihonbashi Life Science Building 2 3-11-5 Nihonbashi Honcho, Chuo-ku Tokyo M0 JAPAN 103-0023 Director Auriel August 1300 Red River Drive, Suite 1500 Austin TX TEXAS 78701 Director Dennis McWilliams 1300 Red River Drive, Suite 1500 Austin TX TEXAS 78701 Director Other Health Care Decline to Disclose 06b false 2026-03-31 false true true true true In addition to acquiring shares of a U.S. corporation through a share exchange, a financing round was subsequently conducted following such exchange. 0 13499802 13499802 0 false 1 0 0 0 false SONIRE Therapeutics Inc. /S/ Tohru Satoh Tohru Satoh President & CEO 2026-04-15